The above division into categories indicates that the thinking on the subject was not very clear. Naturally, the discussions at the workshop also dealt with the list of establishments that would provide care. The list is limited, of course, because of the standard of equipment and expertise that have to be brought together in order to provide the most appropriate form of treatment and ensure that patients are properly monitored. The consensus that had apparently been reached in July fell apart in November. Consequently, the technical and economic context in which this Initiative is being implemented makes it fundamentally inequitable.
All attention is focused on antiretroviral drugs.
Declared cases of AIDS amount to about 5,000 per year, and it can be supposed that there is massive underreporting, and that the figure should be more like 20,000 cases per year. In terms of access to care, it can be assumed that between 5,000 and 10,000 AIDS patients alone could be identified each year, and could be potentially eligible for antiretroviral treatment. CNTS is the only place where such cases could be identified. There are estimated to be between 30 and 50 cases per year, and they require prolonged triple drug therapy. The duration of this has yet to be determined, but it should not be less than 18 months, according to the present state of our knowledge.